Seelos Therapeutics Delisted From Nasdaq, Will Transition To OTC Market Seelos Therapeutics announces delisting from Nasdaq due to failure to meet equity requirements, with trading set to shift to OTC markets on October 16, 2024.
What's Going On With Seelos Therapeutics Stock Tuesday? Seelos shares are trading higher Tuesday after the company announced that it signed a material transfer agreement to supply SLS-002 for the Department of Defense's Military and Veterans Adaptative Platform Clinical Trial for PTSD.
SEEL Stock Earnings: Seelos Therapeutics Beats Revenue for Q2 2024 SEEL stock results show that Seelos Therapeutics beat on revenue for the second quarter of 2024.
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves Jamaica introduces its first legal psilocybin products in pharmacies through a historic partnership between PATOO and Fontana Pharmacy.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday Pre-market stock movers are worth checking out on Wednesday as we break down all of the biggest news worth reading this morning!
3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers These psychedelic drug stocks aren't as radical as once thought as institutional awareness and emphasize on their potential increases.
SEEL Stock Earnings: Seelos Therapeutics Beats EPS, Beats Revenue for Q1 2024 SEEL stock results show that Seelos Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
